vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and OLAPLEX HOLDINGS, INC. (OLPX). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $105.1M, roughly 2.0× OLAPLEX HOLDINGS, INC.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -12.5%, a 69.8% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $32.6M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Olaplex Holdings, Inc. is a specialty beauty company developing and selling patented bond-repair hair care products. It runs three core segments: professional salon distribution, direct-to-consumer sales, and third-party retail, serving customers across North America, Europe, and Asia-Pacific with products that repair and protect damaged hair.
IDYA vs OLPX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $105.1M |
| Net Profit | $119.2M | $-13.1M |
| Gross Margin | — | 68.0% |
| Operating Margin | 52.2% | -4.3% |
| Net Margin | 57.4% | -12.5% |
| Revenue YoY | — | 4.3% |
| Net Profit YoY | 330.1% | -48.9% |
| EPS (diluted) | $1.33 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $105.1M | ||
| Q3 25 | $207.8M | $114.6M | ||
| Q2 25 | — | $106.3M | ||
| Q1 25 | — | $97.0M | ||
| Q4 24 | — | $100.7M | ||
| Q3 24 | $0 | $119.1M | ||
| Q2 24 | $0 | $103.9M | ||
| Q1 24 | $0 | $98.9M |
| Q4 25 | — | $-13.1M | ||
| Q3 25 | $119.2M | $11.1M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | — | $465.0K | ||
| Q4 24 | — | $-8.8M | ||
| Q3 24 | $-51.8M | $14.8M | ||
| Q2 24 | $-52.8M | $5.8M | ||
| Q1 24 | $-39.6M | $7.7M |
| Q4 25 | — | 68.0% | ||
| Q3 25 | — | 69.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 69.5% | ||
| Q4 24 | — | 66.3% | ||
| Q3 24 | — | 68.6% | ||
| Q2 24 | — | 69.7% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | — | -4.3% | ||
| Q3 25 | 52.2% | 3.7% | ||
| Q2 25 | — | -1.1% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 23.5% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 19.8% |
| Q4 25 | — | -12.5% | ||
| Q3 25 | 57.4% | 9.7% | ||
| Q2 25 | — | -7.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | -8.7% | ||
| Q3 24 | — | 12.4% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 7.8% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $1.33 | $0.02 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.60 | $0.02 | ||
| Q2 24 | $-0.68 | $0.01 | ||
| Q1 24 | $-0.53 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $318.7M |
| Total DebtLower is stronger | — | $352.3M |
| Stockholders' EquityBook value | $1.1B | $879.4M |
| Total Assets | $1.2B | $1.5B |
| Debt / EquityLower = less leverage | — | 0.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $318.7M | ||
| Q3 25 | $786.9M | $286.4M | ||
| Q2 25 | — | $289.3M | ||
| Q1 25 | — | $580.9M | ||
| Q4 24 | — | $586.0M | ||
| Q3 24 | $920.0M | $538.8M | ||
| Q2 24 | $701.7M | $507.9M | ||
| Q1 24 | $698.8M | $507.5M |
| Q4 25 | — | $352.3M | ||
| Q3 25 | — | $352.1M | ||
| Q2 25 | — | $351.9M | ||
| Q1 25 | — | $649.1M | ||
| Q4 24 | — | $650.5M | ||
| Q3 24 | — | $651.8M | ||
| Q2 24 | — | $653.1M | ||
| Q1 24 | — | $654.4M |
| Q4 25 | — | $879.4M | ||
| Q3 25 | $1.1B | $888.7M | ||
| Q2 25 | — | $874.2M | ||
| Q1 25 | — | $878.3M | ||
| Q4 24 | — | $874.4M | ||
| Q3 24 | $1.2B | $879.7M | ||
| Q2 24 | $931.7M | $863.3M | ||
| Q1 24 | $935.3M | $855.7M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | $973.7M | $1.8B | ||
| Q1 24 | $961.5M | $1.8B |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.40× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $32.7M |
| Free Cash FlowOCF − Capex | $142.2M | $32.6M |
| FCF MarginFCF / Revenue | 68.4% | 31.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $58.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $32.7M | ||
| Q3 25 | $142.2M | $8.0M | ||
| Q2 25 | — | $20.9M | ||
| Q1 25 | — | $-2.9M | ||
| Q4 24 | — | $49.7M | ||
| Q3 24 | $-49.2M | $33.5M | ||
| Q2 24 | $-32.9M | $16.2M | ||
| Q1 24 | $-43.8M | $43.7M |
| Q4 25 | — | $32.6M | ||
| Q3 25 | $142.2M | $7.9M | ||
| Q2 25 | — | $20.8M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | — | $49.2M | ||
| Q3 24 | $-49.7M | $33.3M | ||
| Q2 24 | $-33.9M | $16.1M | ||
| Q1 24 | $-45.1M | $43.3M |
| Q4 25 | — | 31.0% | ||
| Q3 25 | 68.4% | 6.9% | ||
| Q2 25 | — | 19.6% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | — | 48.9% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | — | 15.5% | ||
| Q1 24 | — | 43.7% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 0.72× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.26× | ||
| Q2 24 | — | 2.81× | ||
| Q1 24 | — | 5.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
